SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agouron Pharmaceuticals (AGPH)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Will Royston who wrote (478)3/15/1997 1:30:00 PM
From: Michael Ades   of 6136
 
Didn't trade
>1,000 shares at average of 36. (shared acct.)
Hold for long term, but I did play the options
Great long term outlook: If 1999 revenues are 255M (low estimates) and they earn about $9 a share, with a P/E of 30, that would be stock price of 270. That's a low revenue estimate with nothing else on the market. I don't mind waiting over 2 years to tripple from where stock is (just my opinion, don't beat me up).
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News